richard hemming, page-31

its amazing how he refers to one sentence of the nomura report, turns it around with stating that whole paragraph and uses that as a way to back up his case, even though he didnt state the positive results that came out of the trial.

below is the full paragraph taken from the nomura report.

C-Vac results
19% of patients responded to therapy (CA-125 reduction or prolonged stabilization) and
47% of patients had disease stabilization (CA-125 remained stable):
• No C-Vac therapy-related toxicity
• Ovarian tumours respond to therapy with CA125 reduction or stabilization
• Progression Free Survival averaged 127 days (95% confidence limits 96 to 219 days)
We note that these were not statistically significant results. Hence, the Phase III clinical
trial will assess statistical significance of the response to C-Vac.

If the report was stating how 'apparently bad' the results were to date, and likely to be then why was it "initiating coverage with a buy recommendation with a target of 31c". I wish i knew what his motives were. Maybe the final scare before upcoming postive results, to try and get in whilst everyone is running? noone knows i guess.